153 related articles for article (PubMed ID: 18081652)
21. Clinical stem cell therapies for severe autoimmune diseases.
Snowden JA; Martin-Rendon E; Watt SM
Transfus Med; 2009 Oct; 19(5):223-34. PubMed ID: 19747285
[TBL] [Abstract][Full Text] [Related]
22. Current international perspectives on hematopoietic stem cell transplantation for inherited metabolic disorders.
Boelens JJ; Prasad VK; Tolar J; Wynn RF; Peters C
Pediatr Clin North Am; 2010 Feb; 57(1):123-45. PubMed ID: 20307715
[TBL] [Abstract][Full Text] [Related]
23. Hematopoietic stem cell transplantation for pediatric autoimmune disease: where we stand and where we need to go.
Krauss AC; Kamani NR
Bone Marrow Transplant; 2009 Aug; 44(3):137-43. PubMed ID: 19597421
[TBL] [Abstract][Full Text] [Related]
24. The A-B-C of haematopoietic stem cell transplantation.
Rafeah NT; Fadilah SA
Med J Malaysia; 2009 Mar; 64(1):94-100; quiz 101. PubMed ID: 19852335
[TBL] [Abstract][Full Text] [Related]
25. Autoimmune disease after autologous hematopoietic stem cell transplantation.
Bohgaki T; Atsumi T; Koike T
Autoimmun Rev; 2008 Jan; 7(3):198-203. PubMed ID: 18190878
[TBL] [Abstract][Full Text] [Related]
26. Cell therapy for autoimmune diseases.
Dazzi F; van Laar JM; Cope A; Tyndall A
Arthritis Res Ther; 2007; 9(2):206. PubMed ID: 17367542
[TBL] [Abstract][Full Text] [Related]
27. Non-endocrine late complications in children after allogeneic haematopoietic SCT.
Faraci M; Békássy AN; De Fazio V; Tichelli A; Dini G;
Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S49-57. PubMed ID: 18545245
[TBL] [Abstract][Full Text] [Related]
28. [Trends in stem cell manipulation ex vivo].
Batinić D
Acta Med Croatica; 2009 Jun; 63(3):231-6. PubMed ID: 19827351
[TBL] [Abstract][Full Text] [Related]
29. Mesenchymal stem cells for the treatment of refractory pure red cell aplasia after major ABO-incompatible hematopoietic stem cell transplantation.
Fang B; Song Y; Li N; Li J; Han Q; Zhao RC
Ann Hematol; 2009 Mar; 88(3):261-6. PubMed ID: 18769919
[TBL] [Abstract][Full Text] [Related]
30. Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.
Vija L; Farge D; Gautier JF; Vexiau P; Dumitrache C; Bourgarit A; Verrecchia F; Larghero J
Diabetes Metab; 2009 Apr; 35(2):85-93. PubMed ID: 19230736
[TBL] [Abstract][Full Text] [Related]
31. Impaired B-cell reconstitution in lymphoma patients undergoing allogeneic HSCT: an effect of pretreatment with rituximab?
Buser A; Stern M; Arber C; Medinger M; Halter J; Rovo A; Favre G; Lohri A; Tichelli A; Gratwohl A
Bone Marrow Transplant; 2008 Oct; 42(7):483-7. PubMed ID: 18695668
[TBL] [Abstract][Full Text] [Related]
32. Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation.
Fagius J; Lundgren J; Oberg G
Mult Scler; 2009 Feb; 15(2):229-37. PubMed ID: 18805841
[TBL] [Abstract][Full Text] [Related]
33. Haematopoietic stem cell transplantation for patients with primary cutaneous T-cell lymphoma.
Duarte RF; Schmitz N; Servitje O; Sureda A
Bone Marrow Transplant; 2008 Apr; 41(7):597-604. PubMed ID: 18176611
[TBL] [Abstract][Full Text] [Related]
34. Prolongation of cardiac allograft survival by syngeneic hematopoietic stem/progenitor cell transplantation in mice.
Li J; Meng X; Tao K; Dou K
Adv Ther; 2008 Sep; 25(9):935-42. PubMed ID: 18758696
[TBL] [Abstract][Full Text] [Related]
35. Current status of autologous hematopoietic stem cell transplantation in myeloma.
Mehta J; Singhal S
Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S28-S34. PubMed ID: 18724294
[TBL] [Abstract][Full Text] [Related]
36. Hematopoietic SCT for peripheral T-cell lymphoma.
Gutiérrez A; Caballero MD; Pérez-Manga G; Rodriguez J
Bone Marrow Transplant; 2008 Dec; 42(12):773-81. PubMed ID: 18936735
[TBL] [Abstract][Full Text] [Related]
37. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myelogenous leukemia in adults: an evidence-based review.
Oliansky DM; Appelbaum F; Cassileth PA; Keating A; Kerr J; Nieto Y; Stewart S; Stone RM; Tallman MS; McCarthy PL; Hahn T
Biol Blood Marrow Transplant; 2008 Feb; 14(2):137-80. PubMed ID: 18215777
[TBL] [Abstract][Full Text] [Related]
38. Where should adolescents with ALL be treated?
Dini G; Banov L; Dini S;
Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S35-9. PubMed ID: 18978742
[TBL] [Abstract][Full Text] [Related]
39. Secondary antifungal prophylaxis in paediatric allogeneic haematopoietic stem cell recipients.
Allinson K; Kolve H; Gumbinger HG; Vormoor HJ; Ehlert K; Groll AH
J Antimicrob Chemother; 2008 Mar; 61(3):734-42. PubMed ID: 18238891
[TBL] [Abstract][Full Text] [Related]
40. Autologous and allogeneic hematopoietic stem cell transplantation for Multiple Sclerosis: perspective on mechanisms of action.
Van Wijmeersch B; Sprangers B; Dubois B; Waer M; Billiau AD
J Neuroimmunol; 2008 Jul; 197(2):89-98. PubMed ID: 18541311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
